nDatalyze Corp (NDAT) AI Stock Analysis

nDatalyze Corp

(CNQX:NDAT)

Select Model

Rating:41Neutral

Price Target:CAD 0.06▼(-11.43% Downside)

Action:reiterated

Date:04/03/26

Dominant financial distress from revenue plunge and cash burn drives low score, partially offset by technical uptrend above key moving averages; negative valuation reinforces high risk.

Positive Factors

Debt-free balance sheetA zero-debt structure materially reduces solvency risk and gives management flexibility to fund operations or strategic initiatives without immediate interest burden. Over 2-6 months this lower fixed-cost profile preserves optionality for financing, partnerships, or restructuring while cash burn is addressed.

Negative Factors

Revenue collapseA multi-year, near-total revenue decline erodes the company’s ability to leverage fixed costs and sustain critical operations. Over months this structural revenue failure undermines partner confidence, limits reinvestment capacity, and makes achieving break-even or scaling the subscription model materially more difficult without a clear demand turnaround.

nDatalyze Corp (NDAT) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 2.89M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -16.7
Beta (1Y): -0.21
Revenue Growth: ―
EPS Growth: 0.00%
Country: Canada
Employees: 1
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Healthcare Information Services

nDatalyze Corp Business Overview & Revenue Model

Company Description

nDatalyze Corp., established in 2018 and based in Calgary, Canada, specializes in developing innovative technology-driven solutions for the health sector. Its current primary focus includes the creation of an online mental health application for cons...

How the Company Makes Money

nDatalyze Corp. generates revenue primarily through the licensing and subscription model of its software tools and platforms. These platforms provide organizations, healthcare providers, and individuals with valuable insights into mental health data....

nDatalyze Corp Financial Statement Overview

Summary

Severe revenue collapse from $662K to $1.7K, massive operating losses (-323% net margin), and deep negative cash flows (-$466K annually) outweigh debt-free balance sheet; overall deterioration signals high operational risk.

Income Statement

12Very Negative

Balance Sheet

45Neutral

Cash Flow

8Very Negative

Financial statement breakdown
Breakdown	TTM	May 2024	May 2022	Feb 2021	Feb 2020	Feb 2019
Income Statement
Total Revenue	1,714	1,714	171.22K	424.93K	662.77K	162.39K
Gross Profit	74	1,553	44.84K	229.98K	376.73K	107.45K
EBITDA	-552.51K	-636.00K	-1.23M	-1.17M	-688.51K	-253.42K
Net Income	-554.48K	-554.48K	-1.23M	-1.17M	-698.53K	-256.96K
Balance Sheet
Total Assets	560.64K	560.64K	862.01K	1.71M	872.95K	269.17K
Cash, Cash Equivalents and Short-Term Investments	522.96K	522.96K	742.74K	1.60M	781.39K	143.49K
Total Debt	0	0	0	0	0	0
Total Liabilities	24.48K	24.48K	289.27K	81.42K	71.87K	28.13K
Stockholders Equity	536.16K	536.16K	572.74K	1.63M	801.08K	241.04K
Cash Flow
Free Cash Flow	-466.13K	-466.14K	-1.03M	-1.14M	18.90K	-222.51K
Operating Cash Flow	-466.14K	-466.14K	-1.02M	-1.13M	20.75K	-216.39K
Investing Cash Flow	0	0	-4,386	-13.85K	-1,844	-6,120
Financing Cash Flow	194.99K	194.99K	175.54K	1.95M	168.00K	366.00K

nDatalyze Corp Technical Analysis

Technical Analysis SentimentNeutral

Last Price0.07

Price Trends

50DMA0.07Negative

100DMA0.07Negative

200DMA0.07Positive

Market Momentum

MACD-0.00Negative

RSI44.26Neutral

STOCH0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:NDAT, the sentiment is Neutral. The current price of 0.07 is below the 20-day moving average (MA) of 0.07, below the 50-day MA of 0.07, and above the 200-day MA of 0.07, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 44.26 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:NDAT.

nDatalyze Corp Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

TSE:NDAT against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:VHI	74Outperform	CAD 494.63M	65.77	2.79%	―	53.79%	29.92%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:NDAT	41Neutral	CAD 2.89M	-16.67	-49.83%	―	―	0.00%
TSE:UDOC	41Neutral	CAD 5.18M	-1.59	355.56%	―	614.03%	51.97%
TSE:ADK	40Underperform	CAD 40.34M	-8.11	9999.00%	―	-36.92%	13.03%
TSE:AIDR	38Underperform	CAD 44.56M	-1.64	-444.52%	―	415.06%	-54.80%

* Healthcare Sector Average

Performance Comparison

TSE:NDAT and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:NDAT	nDatalyze Corp	0.07	0.06	366.67%
TSE:ADK	Diagnos Inc	0.34	-0.01	-1.47%
TSE:VHI	Vitalhub Corp.	7.80	-3.07	-28.24%
TSE:AIDR	Rocket Doctor Ai Inc	0.44	-0.44	-50.00%
TSE:UDOC	Unidoc Health Corp.	0.06	-0.13	-68.42%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Apr 02, 2026

nDatalyze Corp AI Stock Analysis